Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Talc pleurodesis in malignant pleural effusions].

S Kolschmann1, A Ballin, U-R Juergens

  • 1Robert Koch-Klinik, Klinikum St. Georg Leipzig.

Pneumologie (Stuttgart, Germany)
|February 8, 2006
PubMed
Summary

Malignant pleural effusions, causing shortness of breath, are effectively treated with thoracoscopic talc poudrage, achieving over 90% success. This procedure induces pleural symphysis, though rare complications like adult respiratory distress syndrome (ARDS) are linked to small talc particles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutting Waste in Bronchoscopy: A Multicenter Observational Study in the German Health Care System.

Chest·2026
Same author

Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.

Respiratory research·2024
Same author

Storylines for unprecedented heatwaves based on ensemble boosting.

Nature communications·2023
Same author

[German S1 Guideline Long-/Post-COVID].

Pneumologie (Stuttgart, Germany)·2022
Same author

Quality of life and fear of COVID-19 in 2600 baccalaureate nursing students at five universities: a cross-sectional study.

Health and quality of life outcomes·2021
Same author

[Management of Adult Community-Acquired Pneumonia and Prevention - Update 2021 - Guideline of the German Respiratory Society (DGP), the Paul-Ehrlich-Society for Chemotherapy (PEG), the German Society for Infectious Diseases (DGI), the German Society of Medical Intensive Care and Emergency Medicine (DGIIN), the German Viological Society (DGV), the Competence Network CAPNETZ, the German College of General Practitioneers and Family Physicians (DEGAM), the German Society for Geriatric Medicine (DGG), the German Palliative Society (DGP), the Austrian Society of Pneumology Society (ÖGP), the Austrian Society for Infectious and Tropical Diseases (ÖGIT), the Swiss Respiratory Society (SGP) and the Swiss Society for Infectious Diseases Society (SSI)].

Pneumologie (Stuttgart, Germany)·2021

Area of Science:

  • Pulmonology
  • Oncology
  • Thoracic Surgery

Context:

  • Malignant pleural effusions occur in approximately 20% of cancer patients.
  • Large effusions primarily cause dyspnea, along with cough and chest pain, influenced by effusion size and patient's pulmonary function.

Purpose:

  • To evaluate the efficacy and safety of thoracoscopic talc poudrage for managing malignant pleural effusions.
  • To discuss patient selection criteria and potential complications associated with talc pleurodesis.

Summary:

  • Thoracoscopic talc poudrage (2.5-10 g) is a highly effective therapy (>90% success rate) for controlling recurrent malignant pleural effusions.
  • Talc induces pleural inflammation and fibrosis, leading to symphysis. The procedure is suitable for patients in good condition with expected survival >30 days (Karnofsky Performance Scale ≥40).

Related Experiment Videos

  • Adult respiratory distress syndrome (ARDS) is a significant complication (up to 9%), particularly associated with small talc particles (<15 microm).

    • Impact:

    • Talc poudrage or slurry (particle size >10 microm) offers a safe and effective method for inducing pleural symphysis in malignant pleural effusions.
    • Complications like chest pain, fever, and empyema are rare and typically linked to the procedure itself.